Else Launches Child and Adult Nutrition R&D Division
(firmenpresse) - The new state-of-the-art facility, will be home base for Elses early-age nutrition scientists, who will expand the Companys product portfolio through innovation that will bring healthier growth nutrition for children and adults worldwide
VANCOUVER, BC , December 15, 2020 - ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company announces that as part of its mission to create real alternatives for parents who seek cleaner, whole, balanced and sustainable ways to nourish their children, that it has officially opened a new product research and development (R&D) division.
The newly expanded team of Elses nutrition scientists and engineers equipped with state of the art new lab in the north of Israel. The team will leverage the companys robust intellectual property (IP) portfolio and will use the innovation lab to develop future portfolio products spanning infant, toddler children and adult nutrition segments, as well as other food category segments. The facilitys capabilities facilitate robust quality control throughout the production process.
This marks an exciting milestone in the next phase of our growth, expanding on our capabilities as pioneers in the Plant-Based nutrition space, said Mrs. Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. This innovation lab will serve as a springboard of new products and for years to come, and were looking forward to continue delivering novel, Clean Label, Plant-Based consumers solutions globally, she added.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else''s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children''s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children''s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or (at)elsenutrition on Facebook and Instagram.
Media Contact
Covet Consumer Business Unit
Gianna Totaro
elsenutrition(at)powerdigitalmarketing.com
P: 1-301-875-6574
For more information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: hamutaly(at)elsenutrition.com
P: +972(0)3-6445095
Mr. Sokhie Puar, Director of Else Nutrition
Email: sokhiep(at)elsenutrition.com
Telephone: 604-603-7787
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute forward-looking statements within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as will or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Companys financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on managements perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect managements expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Havn Life Sciences announces $5 million Bought Deal Financing">
" alt="Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line">
Datum: 15.12.2020 - 07:05 Uhr
Sprache: Deutsch
News-ID 1563144
Anzahl Zeichen: 3866
contact information:
Contact person:
Town:
Wien
Phone:
Kategorie:
Business News
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 337 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Else Launches Child and Adult Nutrition R&D Division
"
steht unter der journalistisch-redaktionellen Verantwortung von
Else Nutrition Holdings Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
